Skip to main content
Boston Scientific8-K: COO change

Boston Scientific promotes Cardiovascular Group President Joe Fitzgerald to COO, effective Jan 1, 2027.

Source: Autobound Signal API · 115 signals tracked for Boston Scientific · updated

Get Boston Scientific's live signals in Claude or ChatGPT, or by API

AskWhat changed at Boston Scientific this week? Use Autobound signals for bostonscientific.com.

What happened

The promotion of a long-tenured division head to COO signals a focus on operationalizing strategies from the company's core Cardiovascular business across the wider organization.

Source

SEC EDGAROct 7, 2026

Current report (Form 8-K)

Boston Scientific 8-K

Filing excerpt

On October 7, 2026, Boston Scientific Corporation (the “Company”) announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027.

sec.gov/Archives/edgar/data/885725/000088572526000064/bsx-20261001.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: COO change

What this signalsA new leader often reviews the tools the team uses.

Form
8-K
Fiscal year end
10/01
Filed
Oct 7, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$7M (Annual equity award grant value for new COO in 2027)
PercentAnnual bonus incentive target as a percentage of base salary for the new COO
1.1%

Details

CIK
885725
Accession number
0000885725-26-000064
Timeframe
Next quarter
Filing year
2026
Why it matters
Operations vendor review
Signal category
Leadership

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Oct 13, 2026
signal_type
sec-8k
signal_subtype
cooChange

Use this data

Get every 8-K signal for Boston Scientific and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/763d8c3f-e03f-4443-88c5-e82567cebb3f returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.

{
  "signal_id": "763d8c3f-e03f-4443-88c5-e82567cebb3f",
  "signal_type": "sec-8k",
  "signal_subtype": "cooChange",
  "detected_at": "2026-10-13T07:05:21.439+00:00",
  "company": {
    "name": "Boston Scientific",
    "domain": "bostonscientific.com"
  },
  "data": {
    "detail": "The promotion of a long-tenured division head to COO signals a focus on operationalizing strategies from the company's core Cardiovascular business across the wider organization. This transition often triggers reviews of existing operational systems, supply chain vendors, and efficiency-driving technologies, creating opportunities for new solution providers within the first 90 days of his tenure.",
    "metrics": {
      "pct": 1.1,
      "timeframe": "next_quarter",
      "pct_context": "Annual bonus incentive target as a percentage of base salary for the new COO",
      "dollar_context": "Annual equity award grant value for new COO in 2027",
      "dollar_millions": 7
    },
    "summary": "Boston Scientific promotes Cardiovascular Group President Joe Fitzgerald to COO, effective Jan 1, 2027.",
    "excerpts": "On October 7, 2026, Boston Scientific Corporation (the “Company”) announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000064/bsx-20261001.htm",
    "filing_date": "2026-10-07",
    "filing_year": 2026,
    "fiscal_year_end": "10/01",
    "sales_relevance": "Operations vendor review",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.